Efficacy of Drotaverine for Upper Abdominal Pain

Clinical Applications in Gastrointestinal Disorders

• Antispasmodics as a class are recommended for treating abdominal pain in IBS, with guidelines suggesting they are effective for global symptoms and abdominal pain (recommendation: weak, quality of evidence: very low) 1, 2
• The American Gastroenterological Association (AGA) suggests using antispasmodics in patients with IBS (conditional recommendation, low certainty in evidence) 2

Comparison with Other Antispasmodics

• In network meta-analyses examining efficacy of treatments for IBS pain, antispasmodics as a class ranked second for relief of abdominal pain, after tricyclic antidepressants 3

Potential Side Effects and Precautions

• Common side effects of antispasmodics as a class include dry mouth, visual disturbance, and dizziness 1

Alternative Treatments for Upper Abdominal Pain

• Other treatment options for upper abdominal pain include tricyclic antidepressants used as gut-brain neuromodulators (starting at low doses) 1, 3
• Selective serotonin reuptake inhibitors can be used as second-line therapy for global symptoms in IBS 1
• For specific IBS subtypes, targeted therapies such as linaclotide for IBS with constipation or 5-HT3 receptor antagonists for IBS with diarrhea can be used 1, 4

Clinical Decision Making

• If pain persists despite antispasmodic therapy, consider adding or switching to neuromodulators such as tricyclic antidepressants, which have shown the highest ranking for relief of abdominal pain in IBS 3, 5
• For patients with specific bowel habit subtypes, treatment should be tailored accordingly (e.g., avoiding anticholinergic agents in constipation-predominant conditions) 4